comparemela.com

Latest Breaking News On - Haemato - Page 2 : comparemela.com

HAEMATO AG with a strong start into the year 2023:   Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result

EQS-News: HAEMATO AG / Key word: Quarterly / Interim Statement HAEMATO AG with a strong start into the year 2023:   Revenue increase of over 25% compared to the same quarter of the. | May 31, 2023

HAEMATO AG: Dividend of EUR 1 20 | MarketScreener

EQS-News: HAEMATO AG / Key word: Dividend HAEMATO AG: Dividend of EUR 1.20 16.05.2023 / 17:40 CET/CEST The issuer is solely responsible for the content of this. | May 16, 2023

Original-Research: HAEMATO AG (von GBC AG): BUY

17.04.2023 - ^ Original-Research: HAEMATO AG - von GBC AG Einstufung von GBC AG zu HAEMATO AG Unternehmen: HAEMATO AG ISIN: DE000A289VV1 Anlass der Studie: Research Comment Empfehlung: BUY Kursziel: 31.70 EUR Kursziel auf Sicht von: 31.12.2023 Letzte .

HAEMATO AG publishes preliminary figures for the 2022 financial year: Strong increase in net profit and operating cash flow

EQS-News: HAEMATO AG / Key word: Preliminary Results HAEMATO AG publishes preliminary figures for the 2022 financial year: Strong increase in net profit and operating cash flow. | April 13, 2023

DGAP-News: HAEMATO AG publishes figures for Q1 2022: further improvement in EBIT margin and confirmation of guidance Seite 1

23.05.2022 - DGAP-News: HAEMATO AG / Key word(s): Quarter Results/Quarterly / Interim Statement HAEMATO AG publishes figures for Q1 2022: further improvement in EBIT margin and confirmation of guidance 23.05.2022 / 08:30 The issuer is solely responsible for . Seite 1

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.